The infectious disease specialist at the Institut hospitalo universitaire Mediterranee Infection in Marseille recommends Plaquenil (hydrochloroquine, combined with an antibiotic, lopinavir or ritonavir) to combat Covid-19.
He maintains that this treatment made it possible for the coronavirus SARS-Cov-2 to disappear in three-quarters of the patients he had treated.
But since this media coverage, patients rushed to their treating physicians or pharmacies to obtain these drugs, raising fears of a shortage for patients who really need them to treat HIV, lupus, rheumatoid arthritis…
Thus, a decree published on March 26 in the “Official Journal” as well as recommendations from the National Medicines Safety Agency (ANSM) come to frame the delivery of hydroxychloroquine (Plaquenil) and the lopinavir / ritonavir (Kaletra) association. ) in particular in the city, where difficulties in accessing these drugs have been noted.
While hydroxychloroquine and lopinavir / ritonavir can be administered in the hospital, as part of a strict protocol to patients with Covid-19, Plaquenil and Kaletra have no indication for the management charge of Covid-19 in town.
The National Medicines Safety Agency (ANSM) asks community pharmacists not to deliver these treatments “only on medical prescription in their usual indications, to chronic patients who need it“she said in a statement.